Gene · 9760
Papers2,030
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,030
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LEF1 Drives a Central Memory Program and Supports Antitumor Activity of Natural Killer T Cells. | Cancer Immunol Res | 2023 | 36484736 | PubTator, text mining | PubMed |
| Age-associated remodeling of T cell immunity and metabolism. | Cell Metab | 2023 | 36473467 | PubTator, text mining | PubMed |
| Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones. | JCI Insight | 2023 | 36445762 | PubTator, text mining | PubMed |
| Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy. | Semin Immunopathol | 2023 | 36414693 | PubTator, text mining | PubMed |
| T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy. | Clin Cancer Res | 2023 | 36413126 | PubTator, text mining | PubMed |
| Immune predictors of hepatitis B surface antigen seroconversion in patients with hepatitis B reactivation. | Aliment Pharmacol Ther | 2023 | 36411952 | PubTator, text mining | PubMed |
| Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR. | Cancer Immunol Res | 2023 | 36409926 | PubTator, text mining | PubMed |
| ILC1: Development, maturation, and transcriptional regulation. | Eur J Immunol | 2023 | 36408791 | PubTator, text mining | PubMed |
| Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion. | Am J Clin Dermatol | 2023 | 36399227 | PubTator, text mining | PubMed |
| Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells. | Cancer Immunol Immunother | 2023 | 36342511 | PubTator, text mining | PubMed |
| The kinetics of blast clearance are associated with copy number alterations in childhood B-cell acute lymphoblastic leukemia. | Neoplasia | 2023 | 36288679 | PubTator, text mining | PubMed |
| From thymus to tissues and tumors: A review of T-cell biology. | J Allergy Clin Immunol | 2023 | 36272581 | PubTator, text mining | PubMed |
| Technology meets TILs: Deciphering T cell function in the -omics era. | Cancer Cell | 2023 | 36206755 | PubTator, text mining | PubMed |
| GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells. | Cell Mol Gastroenterol Hepatol | 2023 | 36155259 | PubTator, text mining | PubMed |
| Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma. | Blood | 2023 | 36122387 | PubTator, text mining | PubMed |
| Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma. | Int J Cancer | 2023 | 36104949 | PubTator, text mining | PubMed |
| Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia. | Curr Pediatr Rev | 2023 | 36056858 | PubTator, text mining | PubMed |
| Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus. | J Cancer Res Clin Oncol | 2023 | 36042047 | PubTator, text mining | PubMed |
| Aberrant T-cell exhaustion in severe combined immunodeficiency survivors with poor T-cell reconstitution after transplantation. | J Allergy Clin Immunol | 2023 | 35987350 | PubTator, text mining | PubMed |
| Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations. | Blood Adv | 2023 | 35947128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9760/papers?page=34